Eytan Breman

Eytan Breman is a skilled professional with extensive experience in research and development. Eytan has held various roles at Celyad Oncology, LUMC, UMC Utrecht, Leiden University, and azM. Eytan's focus has been on transplant immunology, drug delivery, biopharmaceutical sciences, and immunology. Eytan's work involves developing methods for monitoring indirect allorecognition in renal transplant recipients and investigating the role of sphingosine-1-phosphate metabolism in atherosclerosis development. With a Doctor of Philosophy in transplant immunology and a Master of Science in bio-pharmacy, Eytan is a dedicated and knowledgeable individual in the field.